Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
77M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
12.8M
-
Shares change
-
-5.76M
-
Total reported value, excl. options
-
$13.7M
-
Value change
-
-$30.8M
-
Put/Call ratio
-
0
-
Number of buys
-
29
-
Number of sells
-
-56
-
Price
-
$1.07
Significant Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q4 2018
101 filings reported holding CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value as of Q4 2018.
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.8M shares
of 77M outstanding shares and own 16.6% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (2.25M shares), BlackRock Inc. (1.9M shares), SPHERA FUNDS MANAGEMENT LTD. (1.19M shares), UBS Group AG (912K shares), NORTHPOINTE CAPITAL LLC (563K shares), Vanguard Group Inc (560K shares), MILLENNIUM MANAGEMENT LLC (548K shares), DEUTSCHE BANK AG\ (537K shares), RENAISSANCE TECHNOLOGIES LLC (506K shares), and STATE STREET CORP (446K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.